|
Teams:
Molecular Pathogenesis and Aetiology
of Leukaemia:
Team Leader: Prof M Greaves more
information
Molecular
Haematology :
Team Leader: Prof G Morgan more
information
Transcriptional
Regulation :
Team Leader: Dr A Zelent more
information
Molecular
Cytogenetics of Leukaemia:
Team Leader: Dr L Kearney more
information
Targeted
Treatment of Myeloma:
Team Leader:
Dr F Davies more information
Leukaemogenesis:
Team Leader:
Dr E So more information
New
Team :
Team Leader: Team to be developed. More information
coming soon.
Section Introduction:
The section of Haemato-Oncology was formed in January 2004
and incorporates several distinct teams (detailed above).
This is one of the most comprehensive and influential research/clinical
centres for haematological malignancies in Europe.
Aims:
To improve patient outcomes by developing new research-based
treatments.
Location:
The section is geographically divided between The Brookes
Lawley Building and Royal Marsden Hospital in Sutton and
The Chester Beatty Laboratories in Chelsea. The section
will ultimately be based entirely in Sutton.
BROOKES
LAWLEY BUILDING, ICR, COTSWOLD RD, SUTTON
|